Zephyrnet Logo

Tag: cancer drug

Drugmakers Escape Cancer Drug Antitrust Claims For Now – Law360

By Jared Foretek (June 6, 2024, 9:01 PM EDT) -- A New Jersey federal judge granted drugmakers Celgene and Bristol-Myers Squibb an out...

Top News

The Ibrunitib Saga: DHC Restrains Generic Competitors, but What about Public Interest?

The Ibrutinib Patent Dispute Adding another chapter to the long-standing legal dispute concerning the Leukaemia medication Imbruvica (API Ibrutinib), the Delhi High Court on December...

Intellectual Property as a Catalyst: Promoting Inclusiveness, Empowerment, and Development

INTRODUCTION “The future of the nation depends in no small part on the efficiency of industry, and the efficiency of the industry depends in no...

The big potential of MOFs in tackling fundamental problems

Dec 27, 2023 (Nanowerk News) Metal organic frameworks (MOFs) are advanced porous materials with multifunctional tunable properties. Discovered approximately 20 years ago, these sponge-like molecule...

Non-invasive cancer monitoring takes a leap forward with new microfluidic technology

Monitoring cancer cells effectively can help physicians with treatment and management, thus reducing cancer-related mortality. Can non-invasive technologies pave the way for improved monitoring...

NAYA Biosciences and INVO Bioscience Announce Appointment of Dr. Peter Kash, Ed.D., MBA as Vice Chairman Following Closing of Their Pending Merger | BioSpace

SARASOTA, Fla. and AVENTURA, Fla., Nov. 10, 2023 /PRNewswire/ -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO"), a healthcare services company focused on expanding access...

Novartis radiopharmaceutical drug succeeds in first-line gut cancer study

Dive Brief: Novartis’ radiopharmaceutical drug Lutathera met its goal in a Phase 3 trial as a first-line treatment for a type of gastrointestinal cancer, the...

AstraZeneca and Daiichi’s next cancer medicine scores in breast tumors

Dive Brief: A new cancer drug developed by Daiichi Sankyo and AstraZeneca met one of its two main goals in a breast cancer trial, helping...

Breast cancer drug from AstraZeneca, Daiichi hits goal in late-stage trial

LONDON — AstraZeneca said Friday an experimental drug tamped down the progression of a certain type of breast cancer in a Phase 3 trial,...

Genentech takes up a deal to make ‘molecular glue’ drugs

“Molecular glues” — so named for their ability to forcibly pull together two proteins that wouldn’t otherwise interact with each other — have come...

A chemo drug shortage shows the vulnerability of the healthcare supply chains

This article first appeared in The Checkup, MIT Technology Review's weekly biotech newsletter. To receive it in your inbox every Thursday, and read...

Delcath Gets FDA Approval for Cancer Drug-Device Combo 10 Years After Rejection | BioSpace

Pictured: Cancer cells growing on the liver/iStock, Rasi Bhadramani The FDA on Monday approved Delcath Systems’ Hepzato Kit for the liver-directed treatment of adult...

Horizon Therapeutics, Activision among best bets for M&A deals to close

Amgen's (AMGN) planned $28 billion purchase of Horizon Therapeutics (NASDAQ:HZNP) and Microsoft's $69 billion acquisition of video game giant...

Latest Intelligence

spot_img
spot_img